share_log

Therma Bright Provides Update on Cease Trade Order

Therma Bright Provides Update on Cease Trade Order

Therma Bright 提供停止交易令的最新信息
newsfile ·  2023/12/05 23:25

Toronto, Ontario--(Newsfile Corp. - December 5, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, announces that a cease trade order has been issued by the Ontario Securities Commission for not filing the following documents by the periodic disclosure deadline:

安大略省多倫多--(Newsfile Corp.,2023年12月5日)——Therma Bright Inc.(多倫多證券交易所股票代碼:THRM)(場外交易代碼:TBRIF)(“Therma” 或 “公司”),一系列領先的專有診斷和醫療設備技術的開發商和合作夥伴,宣佈安大略省證券委員會已發佈停止交易令,原因是未在定期披露截止日期之前提交以下文件:

  • annual financial statements for the year ended July 31, 2023;
  • management's discussion and analysis relating to the annual financial statements for the year ended July 31, 2023;
  • certification of the foregoing filings as required by National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings.
  • 截至2023年7月31日止年度的年度財務報表;
  • 管理層與截至2023年7月31日止年度的年度財務報表有關的討論和分析;
  • 按照國家儀器52-109發行人年度和中期申報披露證明的要求對上述申報進行認證。

The Company would like to inform shareholders that it is working diligently with its new auditor to file the above documents as soon as they are finalized. The Company does not anticipate a lengthy delay in filing the required documents. Once the documents are filed the Company will request an application to revoke the cease trade order.

公司想告知股東,它正在努力與新任核數師合作,以便在上述文件定稿後立即將其提交。該公司預計在提交所需文件方面不會有長時間的延遲。文件提交後,公司將要求申請撤銷停止交易令。

About Therma Bright Inc.
Therma Bright is a developer and partner in a wide range of leading edge, proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with quality, innovative solutions that address some of today's most important medical and healthcare challenges. Therma Bright Inc. trades on the (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX). Visit: .

關於 Therma Bright Inc
Therma Bright是各種前沿專有診斷和醫療設備技術的開發商和合作夥伴,致力於爲消費者和醫療專業人員提供優質、創新的解決方案,以應對當今一些最重要的醫療和醫療保健挑戰。Therma Bright Inc. 在(多倫多證券交易所股票代碼:THRM)(OTCQB:TBRIF)(FSE:JNX)上市。訪問:。

Therma Bright Inc.
Rob Fia, CEO
rfia@thermabright.com
Follow us on Twitter

Therma Bright公司
首席執行官 Rob Fia
rfia@thermabright.com
在推特上關注我們

FORWARD-LOOKING STATEMENTS
Certain statements in this news release constitute "forward-looking" statements. These statements relate to future events such as the commercialization of DCA and related technology as described in the news release. All such statements involve substantial known and unknown risks, uncertainties and other factors which may cause the actual results to vary from those expressed or implied by such forward-looking statements. Forward-looking statements involve significant risks and uncertainties, they should not be read as guarantees of future performance or results, and they will not necessarily be accurate indications of whether such results will be achieved. Actual results could differ materially from those anticipated due to several factors and risks. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions on the date of this news release, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise, except as required under applicable securities regulations.

前瞻性陳述
本新聞稿中的某些陳述構成 “前瞻性” 陳述。這些聲明與未來事件有關,例如新聞稿中描述的DCA和相關技術的商業化。所有這些陳述都涉及大量已知和未知的風險、不確定性和其他因素,這些因素可能導致實際結果與此類前瞻性陳述所表達或暗示的結果有所不同。前瞻性陳述涉及重大風險和不確定性,不應將其視爲未來業績或業績的保證,也不一定能準確表明是否會取得此類結果。由於多種因素和風險,實際結果可能與預期結果存在重大差異。儘管本新聞稿中包含的前瞻性陳述基於公司管理層認爲截至本新聞稿發佈之日的合理假設,但公司無法向投資者保證實際業績將與這些前瞻性陳述一致。本新聞稿中包含的前瞻性陳述自本文發佈之日起作出,除非適用的證券法規另有要求,否則公司不打算或沒有義務更新或修改任何前瞻性陳述,無論是由於新信息、未來事件還是其他原因。

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論